Yingjun Quan

1.0k total citations
27 papers, 738 citations indexed

About

Yingjun Quan is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Yingjun Quan has authored 27 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Yingjun Quan's work include Genetic factors in colorectal cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Diet and metabolism studies (3 papers). Yingjun Quan is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Diet and metabolism studies (3 papers). Yingjun Quan collaborates with scholars based in China, Australia and Singapore. Yingjun Quan's co-authors include Zhijun Min, Ao Huang, Hongchao Zhao, Bo Feng, Ming Xu, Guohao Wu, Yang Zhou, Jia Wei, Dongxing Cao and Yi Jiang and has published in prestigious journals such as PLoS ONE, Gene and Carcinogenesis.

In The Last Decade

Yingjun Quan

27 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingjun Quan China 15 288 210 173 165 155 27 738
Huan Jin China 11 368 1.3× 158 0.8× 212 1.2× 76 0.5× 135 0.9× 17 817
Johann Gout Germany 14 255 0.9× 263 1.3× 146 0.8× 120 0.7× 56 0.4× 30 594
Valérie Cattan France 15 228 0.8× 186 0.9× 67 0.4× 142 0.9× 171 1.1× 32 813
Emily Harris United States 10 433 1.5× 124 0.6× 192 1.1× 73 0.4× 164 1.1× 60 852
Haichen Sun China 15 312 1.1× 145 0.7× 200 1.2× 166 1.0× 82 0.5× 28 652
Stefan Koschnick Germany 9 224 0.8× 280 1.3× 92 0.5× 139 0.8× 141 0.9× 10 840
William Nassib William United States 14 227 0.8× 339 1.6× 73 0.4× 76 0.5× 91 0.6× 44 810
Yun Zuo China 17 359 1.2× 121 0.6× 192 1.1× 79 0.5× 341 2.2× 29 887
Marc Winslet United Kingdom 17 234 0.8× 216 1.0× 92 0.5× 249 1.5× 46 0.3× 38 722
Shibo Lin China 12 242 0.8× 109 0.5× 115 0.7× 180 1.1× 72 0.5× 38 667

Countries citing papers authored by Yingjun Quan

Since Specialization
Citations

This map shows the geographic impact of Yingjun Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingjun Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingjun Quan more than expected).

Fields of papers citing papers by Yingjun Quan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingjun Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingjun Quan. The network helps show where Yingjun Quan may publish in the future.

Co-authorship network of co-authors of Yingjun Quan

This figure shows the co-authorship network connecting the top 25 collaborators of Yingjun Quan. A scholar is included among the top collaborators of Yingjun Quan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingjun Quan. Yingjun Quan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Luo, Yi, Yang Zhou, Yusheng Chen, Xiaolan Lu, & Yingjun Quan. (2021). Genomic and immunological features of microsatellite instability in colon cancer. Gene. 781. 145534–145534. 5 indexed citations
3.
Chen, Fang, Hongrui Liu, Bing Wang, et al.. (2020). Physiologically Based Pharmacokinetic Modeling to Understand the Absorption of Risperidone Orodispersible Film. Frontiers in Pharmacology. 10. 1692–1692. 14 indexed citations
5.
Chen, Yusheng, et al.. (2020). Interleukin 1β/1RA axis in colorectal cancer regulates tumor invasion, proliferation and apoptosis via autophagy. Oncology Reports. 43(3). 908–918. 19 indexed citations
6.
Liu, Hongrui, et al.. (2019). A Sensitive HPLC-MS/MS Method for the Quantification of Selegiline in Beagle Dog Plasma: Application to a Pharmacokinetic Study. Current Pharmaceutical Analysis. 17(1). 140–148. 1 indexed citations
7.
Zhou, Yang, Yusheng Chen, Dejun Wu, Zhijun Min, & Yingjun Quan. (2019). <p>Analysis of risk factors for colon cancer progression</p>. OncoTargets and Therapy. Volume 12. 3991–4000. 11 indexed citations
8.
Huang, Renhong, Yingjun Quan, Jinhong Chen, et al.. (2017). Osteopontin Promotes Cell Migration and Invasion, and Inhibits Apoptosis and Autophagy in Colorectal Cancer by activating the p38 MAPK Signaling Pathway. Cellular Physiology and Biochemistry. 41(5). 1851–1864. 66 indexed citations
9.
Huang, Renhong, Yingjun Quan, Ao Huang, & Zhijun Min. (2016). Role of Osteopontin in the Carcinogenesis and Metastasis of Colorectal Cancer. Journal of Cancer Therapy. 7(10). 729–740. 3 indexed citations
10.
Quan, Yingjun, Ao Huang, Min Ye, et al.. (2015). Comparison of laparoscopic versus open gastrectomy for advanced gastric cancer: an updated meta-analysis. Gastric Cancer. 19(3). 939–950. 63 indexed citations
11.
Quan, Yingjun, et al.. (2015). Grainyhead-like 2 Promotes Tumor Growth and is Associated with Poor Prognosis in Colorectal Cancer. Journal of Cancer. 6(4). 342–350. 40 indexed citations
12.
Zhao, Hongchao, et al.. (2014). Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection: a meta-analysis. International Journal of Colorectal Disease. 29(3). 321–327. 39 indexed citations
13.
Quan, Yingjun, Runsen Jin, Hongchao Zhao, et al.. (2014). Downregulation of GRHL2 inhibits the proliferation of colorectal cancer cells by targeting ZEB1. Cancer Biology & Therapy. 15(7). 878–887. 44 indexed citations
14.
Huang, Ao, Hongchao Zhao, Yingjun Quan, et al.. (2014). E2A Predicts Prognosis of Colorectal Cancer Patients and Regulates Cancer Cell Growth by Targeting miR-320a. PLoS ONE. 9(1). e85201–e85201. 20 indexed citations
15.
Huang, Ao, et al.. (2013). High expression level of TMPRSS4 predicts adverse outcomes of colorectal cancer patients. Medical Oncology. 30(4). 712–712. 14 indexed citations
16.
Huang, Ao, et al.. (2013). TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability. Cancer Biology & Therapy. 15(3). 297–304. 25 indexed citations
17.
Zhao, Hongchao, Taotao Dong, Linlin Wang, et al.. (2013). miR-320a suppresses colorectal cancer progression by targeting Rac1. Carcinogenesis. 35(4). 886–895. 79 indexed citations
18.
Zhao, Hongchao, Ao Huang, Pu Li, et al.. (2013). E2A suppresses invasion and migration by targeting YAP in colorectal cancer cells. Journal of Translational Medicine. 11(1). 317–317. 19 indexed citations
19.
Cao, Dongxing, Guohao Wu, Bo Zhang, et al.. (2009). Resting energy expenditure and body composition in patients with newly detected cancer. Clinical Nutrition. 29(1). 72–77. 128 indexed citations
20.
Wu, Guohao, Dongxing Cao, Jia Wei, Yingjun Quan, & Zhaohan Wu. (2008). [Assessment of energy expenditure and body composition in cancer patients].. PubMed. 46(24). 1906–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026